蘇文電能(300982.SZ):擬將所持江蘇新運8%股權轉讓給常州新運
格隆匯5月26日丨蘇文電能(300982.SZ)公佈,公司與常州新運簽署《股權轉讓協議》,並與常州新運、裕興股份共同簽署《投資合作協議之補充協議》,經各方友好協商,公司擬將所持江蘇新運8%的股權(對應註冊資本800萬元)以人民幣400萬元的價格轉讓給常州新運,裕興股份擬將其所持江蘇新運4%的股權(對應註冊資本400萬元)以人民幣200萬元的價格轉讓給常州新運。本次股權轉讓完成後,常州新運持有江蘇新運52%的股權(對應註冊資本5,200萬元),公司持有江蘇新運32%的股權(對應註冊資本3,200萬元),裕興股份持有江蘇新運16%的股權(對應註冊資本1,600萬元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.